Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Intricate role of yes-associated protein1 in human liver cirrhosis: TGF-β1 still is a giant player.

Mohagheghi S, Geramizadeh B, Nikeghbalian S, Khodadadi I, Karimi J, Khajehahmadi Z, Gharekhanloo F, Tavilani H.

IUBMB Life. 2019 Oct;71(10):1453-1464. doi: 10.1002/iub.2052. Epub 2019 May 14.

PMID:
31087779
2.

Downregulation of hedgehog ligands in human simple steatosis may protect against nonalcoholic steatohepatitis: Is TAZ a crucial regulator?

Khajehahmadi Z, Mohagheghi S, Nikeghbalian S, Geramizadeh B, Khodadadi I, Karimi J, Ghaffari ME, Tavilani H.

IUBMB Life. 2019 Sep;71(9):1382-1390. doi: 10.1002/iub.2068. Epub 2019 May 14.

PMID:
31087761
3.

Novel Interplay Between Sonic Hedgehog and Transforming Growth Factor-β1 in Human Nonalcoholic Steatohepatitis.

Zhou X, Wang P, Ma Z, Li M, Teng X, Sun L, Wan G, Li Y, Guo L, Liu H.

Appl Immunohistochem Mol Morphol. 2019 Feb 1. doi: 10.1097/PAI.0000000000000724. [Epub ahead of print]

PMID:
30720468
4.

Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.

Liu H, Dong F, Li G, Niu M, Zhang C, Han Y, He L, Yin P, Wang B, Sang X, Li R, Wang J, Bai Z, Xiao X.

J Ethnopharmacol. 2018 Jan 10;210:232-241. doi: 10.1016/j.jep.2017.08.029. Epub 2017 Aug 31.

PMID:
28864168
5.

Aberrant TGF-β1 signaling contributes to the development of primary biliary cirrhosis in murine model.

Liu B, Zhang X, Zhang FC, Zong JB, Zhang W, Zhao Y.

World J Gastroenterol. 2013 Sep 21;19(35):5828-36. doi: 10.3748/wjg.v19.i35.5828.

6.

Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation.

Xiao X, Gang Y, Gu Y, Zhao L, Chu J, Zhou J, Cai X, Zhang H, Xu L, Nie Y, Wu K, Liu Z, Fan D.

Dig Dis Sci. 2012 Nov;57(11):2883-91. doi: 10.1007/s10620-012-2248-7. Epub 2012 Jun 4.

PMID:
22661273
7.

Qinggan Huoxue Recipe suppresses epithelial-to-mesenchymal transition in alcoholic liver fibrosis through TGF-β1/Smad signaling pathway.

Wu T, Chen JM, Xiao TG, Shu XB, Xu HC, Yang LL, Xing LJ, Zheng PY, Ji G.

World J Gastroenterol. 2016 May 21;22(19):4695-706. doi: 10.3748/wjg.v22.i19.4695.

8.

Transforming growth factor betas and their receptors in human liver cirrhosis.

Baer HU, Friess H, Abou-Shady M, Berberat P, Zimmermann A, Gold LI, Korc M, Büchler MW.

Eur J Gastroenterol Hepatol. 1998 Dec;10(12):1031-9.

PMID:
9895050
9.

Role of transforming growth factor-β1 in serum and - 509 C>T promoter gene polymorphism in development of liver cirrhosis in Egyptian patients.

Mohy A, Fouad A.

Meta Gene. 2014 Sep 9;2:631-7. doi: 10.1016/j.mgene.2014.08.002. eCollection 2014 Dec.

10.

[Role of transforming growth factor-beta in the development of some liver diseases].

Raikhelson KL, Karev VE, Marchenko NV, Semenov NV, Palgova LK, Baranovsky AY.

Ter Arkh. 2014;86(2):44-8. Russian.

PMID:
24772507
11.

Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.

Kuriyama S, Yokoyama F, Inoue H, Takano J, Ogawa M, Kita Y, Yoshiji H, Deguchi A, Kimura Y, Himoto T, Yoneyama H, Kurokohchi K, Masaki T, Uchida N, Watanabe S.

Int J Mol Med. 2007 Feb;19(2):317-24.

PMID:
17203207
12.

New Mechanism of Hepatic Fibrogenesis: Hepatitis C Virus Infection Induces Transforming Growth Factor β1 Production through Glucose-Regulated Protein 94.

Jee MH, Hong KY, Park JH, Lee JS, Kim HS, Lee SH, Jang SK.

J Virol. 2015 Dec 30;90(6):3044-55. doi: 10.1128/JVI.02976-15.

13.

[Effects of Anluohuaxianwan on transforming growth factor-β1 and related signaling pathways in rats with carbon tetrachloride-induced liver fibrosis].

Lu W, Gao YH, Wang ZZ, Cai YS, Yang YQ, Miao YQ, Pei F, Liu XE, Zhuang H.

Zhonghua Gan Zang Bing Za Zhi. 2017 Apr 20;25(4):257-262. doi: 10.3760/cma.j.issn.1007-3418.2017.04.005. Chinese.

PMID:
28494543
14.

miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.

Liu Z, Yi J, Ye R, Liu J, Duan Q, Xiao J, Liu F.

Int J Clin Exp Pathol. 2015 Apr 1;8(4):3994-4000. eCollection 2015.

15.

Cryptolepine derivative-6h inhibits liver fibrosis in TGF-β1-induced HSC-T6 cells by targeting the Shh pathway.

He YH, Li Z, Ni MM, Zhang XY, Li MF, Meng XM, Huang C, Li J.

Can J Physiol Pharmacol. 2016 Sep;94(9):987-95. doi: 10.1139/cjpp-2016-0157. Epub 2016 Apr 28.

PMID:
27295431
16.

[Establishment of a complex alcoholic liver fibrosis mouse model and investigation of OPN and TGF-beta1 hepatic expression].

Kong LB, Ren WG, Mi HM, Zhao SX, Zhang YG, Nan YM.

Zhonghua Gan Zang Bing Za Zhi. 2013 Mar;21(3):207-12. Chinese.

PMID:
23967743
17.

[Expression of ADAMTS-2 and TGF-β1 in cirrhotic liver].

Li H, Dong C, Cao T, Chang S.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Oct;37(10):1026-30. doi: 10.3969/j.issn.1672-7347.2012.10.010. Chinese.

18.

Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.

Yu F, Chen B, Fan X, Li G, Dong P, Zheng J.

Cell Physiol Biochem. 2017;43(6):2242-2252. doi: 10.1159/000484303. Epub 2017 Oct 27.

19.

[Role of transforming growth factor beta1 (TGF-beta1) in the pathogenesis and clinical course of chronic hepatitis in children].

Liberek A, Marek A, Kmieć Z, Kartanowicz D, Szlagatys-Sidorkiewicz A, Łuczak G, Wierzbicki PM, Stanisławowski M, Wierzbicki M, Marek K, Liberek T, Sikorska-Wiśniewska G, Góra-Gebka M, Wegrzyn G, Kamińska B.

Med Wieku Rozwoj. 2009 Jul-Sep;13(3):163-70. Polish.

PMID:
20081261
20.

Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.

Zhou Y, Tong X, Ren S, Wang X, Chen J, Mu Y, Sun M, Chen G, Zhang H, Liu P.

J Ethnopharmacol. 2016 Aug 22;190:83-90. doi: 10.1016/j.jep.2016.06.011. Epub 2016 Jun 6.

PMID:
27282665

Supplemental Content

Support Center